BAD - Composition for treating Epstein-Barr virus infection comprising a BAD expression promoter

• 1. 爱泼斯坦－巴尔二氏病毒感染及其治疗药物 [P] . 中国专利： CN105213664A . 2016-01-06
• 2. 用于调节爱泼斯坦-巴尔核抗原1的活性的组合物和方法 [P] . 中国专利： CN103717757A . 2014-04-09
• 3. COMPOSITION COMPRISING BAD EXPRESSION PROMOTER FOR TREATING EPSTEIN-BARR VIRUS INFECTION [P] . 韩国专利： KR20160012935A . 2016-02-03

  机译： 包含表达不良蛋白的组合物，用于治疗上皮蛋白-巴尔病毒感染

• 4. - - Composition for treating Epstein-Barr virus infection comprising a Epstein-Barr virus micro RNA inhibitor [P] . 韩国专利： KR101648256B1 . 2016-08-12

  机译： --包含爱泼斯坦-巴尔病毒微RNA抑制剂的治疗爱泼斯坦-巴尔病毒感染的组合物

• 5. COMPOSITION FOR TREATING EPSTEIN-BARR VIRUS INFECTION COMPRISING A EPSTEIN-BARR VIRUS MICRO RNA INHIBITOR [P] . 韩国专利： KR20150131692A . 2015-11-25

  机译： 包含上皮病毒-BARR病毒微RNA抑制剂的治疗上皮病毒-BARR病毒的组合物

• 1. Expression of matrix metalloproteinase-9 in nasopharyngeal carcinoma and association with Epstein-Barr virus infection [J] . 汤建国, 李旋, 陈萍 浙江大学学报（英文版）（A辑：应用物理和工程） . 2004,第010期
• 2. Expression of matrix metalloproteinase-9 in nasopharyngeal carcinoma and association with Epstein-Barr virus infection [J] . 汤建国, 李旋, 陈萍 浙江大学学报：自然科学英文版 . 2004,第010期
• 3. Seroepidemiology of Toxoplasma, Rubella, Cytomegalovirus and Herpes Simplex Virus -2 in Women with Bad Obstetric History. PART II. Cytomegalovirus and Herpes Simplex Virus Infections [J] . Abdulghani Mohamed Alsamarai, Zainab Khalil Mohamed Aljumaili Our Dermatology Online . 2013,第4期
• 4. Off-the-Shelf Virus-Specific T Cells to Treat BK Virus, Human Herpesvirus 6, Cytomegalovirus, Epstein-Barr Virus, and Adenovirus Infections After Allogeneic Hematopoietic Stem-Cell Transplantation [J] . Tzannou Ifigeneia, Papadopoulou Anastasia, Naik Swati, Journal of Clinical Oncology . 2017,第31期
• 5. Characterization of Epstein-Barr Virus (EBV) BZLF1 Gene Promoter Variants and Comparison of Cellular Gene Expression Profiles in Japanese Patients With Infectious Mononucleosis, Chronic Active EBV Infection, and EBV-Associated Hemophagocytic Lymphohistiocytosis [J] . Masayuki Imajoh, Yumiko Hashida, Masanao Murakami, Journal of Medical Virology . 2012,第6期
• 6. URINARY TRACT INFECTIONS: BAD BUGS BLADDER DRUGS [C] . Joseph W. Bartges Annual Meeting of the American Animal Hospital Association . 2010
• 7. Characterizing Co-infection of Primary B Cells with Kaposi’s Sarcoma-Associated Herpesvirus and Epstein-Barr Virus: Establishing an In Vitro Model of the Development of Primary Effusion Lymphoma [D] . Faure, Aurélia. 2019
• 8. Epstein-Barr Virus MicroRNA miR-BART20-5p Suppresses Lytic Induction by Inhibiting BAD-Mediated caspase-3-Dependent Apoptosis [O] . Hyoji Kim, Hoyun Choi, Suk Kyeong Lee 2016
• 9. Unique Epstein-Barr virus (EBV) latent gene expression, EBNA promoter usage and EBNA promoter methylation status in chronic active EBV infection. [O] . Yoshioka, Mikio, Kikuta, Hideaki, Ishiguro, Nobuhisa, 2003

• 1. Chronic active Epstein-Barr virus infection treated with PEGaspargase: A case report [J] . De-Li Song ,Jing-Shi Wang ,Lei-Lei Chen . 世界临床病例杂志 . 2021,第026期
• 2. H pylori (CagA) and Epstein-Barr virus infection in gastric carcinomas:Correlation with p53 mutation and c-Myc,Bcl-2 and Bax expression [J] . Valeska Portela Lima ,Marcos Antonio Pereira de Lima ,Angela Rosa André . 世界胃肠病学杂志：英文版 . 2008,第6期
• 3. Human cytomegalovirus and Epstein-Barr virus infection in inflammatory bowel disease:Need for mucosal viral load measurement [J] . Rachele Ciccocioppo ,Francesca Racca ,Stefania Paolucci . 世界胃肠病学杂志：英文版 . 2015,第6期
• 4. 用于治疗痹病的中药组合物 [C] . 黄靖 . 第二届海峡两岸地道药材临床应用论坛 . 2015